Alnylam Pharmaceuticals, Inc.
COMPOSITIONS AND METHODS FOR INHIBITIION OF EXPRESSION OF PROTEIN C (PROC) GENES
Last updated:
Abstract:
The invention relates to double-stranded ribonucleic acid (dsRNA) targeting a PROC gene, and methods of using the dsRNA to inhibit expression of PROC.
Status:
Application
Type:
Utility
Filling date:
11 Nov 2019
Issue date:
30 Jul 2020